Adsilico Raises £10 Million for Virtual Medical Device Testing

Oct 27, 2026
University of Leeds spinout adsilico raised £10 million to expand its virtual patient technology for testing medical devices before clinical trials.

University of Leeds spinout adsilico raised £10 million in a Series A round, reports Tech.eu. PXN Ventures led the round, with participation from existing investors Northern Gritstone and Parkwalk.

Adsilico develops Virtual Chimera, a platform that uses generative AI to create virtual hearts and blood vessels from anonymized clinical scans. Physics based simulations let medical device manufacturers assess implants across virtual patients with different ages, sexes, ethnicities, body sizes and medical conditions before clinical trials.

The company will use the funding to develop its virtual heart models, expand into neurovascular devices such as flow diverters for brain aneurysms and increase its workforce. Adsilico has completed projects with heart valve and neurovascular device manufacturers.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.